Rectus Sheath Block: Postoperative Analgesia and Proinflammatory Cytokines
Postoperative Pain

About this trial
This is an interventional prevention trial for Postoperative Pain focused on measuring Rectus sheath block, Postoperative pain,TNF alpha and IL-6
Eligibility Criteria
Inclusion Criteria:
Male patients their age over 40 years, classified ASA I, II or III, undergoing radical resection of cancer prostate, through midline abdominal incision under general anaesthesia.
Exclusion criteria:
Contraindications to rectus sheath block as patient refusal, coagulopathy, local infection and allergy to bupivacaine. Planned transverse or oblique abdominal incision, extensive existing midline abdominal scarring or pre-existing chronic abdominal pain.
Sites / Locations
- Assiut university faculty of medicine
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Rectus Sheath
Control
Each patient received bilateral single shot ultrasound guided rectus sheath block under complete aseptic condition in a dose of 30 ml of bupivacaine 0.25% in each side immediately after induction of general anaesthesia
Control group: the patients did not receive any intervention after anaesthesia induction.